Skip to content
healthcare.dev

Methotrexate

NDC 0143-9830, Methotrexate, injection, powder, lyophilized, for solution, from Hikma Pharmaceuticals USA Inc..

Product NDC
0143-9830
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040632
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9830 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE1 g/1

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
0143-9830-01001439830011 VIAL in 1 BOX (0143-9830-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b080eb92-fc72-4ce6-a7ab-3f9ce2415526
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0143-9830

Use it

Look up 0143-9830 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9830 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0143-9830. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.